Principal Interface. All formulary or marketing approvals shall also be obtained by and in the name of NOVARTIS, and NOVARTIS will be the principal interface with and will otherwise handle all interactions with regulatory agencies concerning any Drug Product including, to the extent legally possible, being the sole contact with such agencies, subject to the rights of VERTEX under Section 3.4.3.
Appears in 3 contracts
Sources: Research and Early Development Agreement (Vertex Pharmaceuticals Inc / Ma), Research and Early Development Agreement (Vertex Pharmaceuticals Inc / Ma), Research and Early Development Agreement (Vertex Pharmaceuticals Inc / Ma)